Pharmacology: Endocrine, Psychotropic, and Neurodegenerative Agents

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/28

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary review flashcards covering endocrine pharmacology, antidiabetic agents, antidepressants, anxiolytics, antipsychotics, and antiparkinsonian drugs.

29 Terms

1
New cards

Selective Estrogen Receptor Modulators (SERMs)

A class of drugs with tissue-specific estrogen agonist or antagonist activity; examples include ospemifene (Osphena) for vaginal dryness, tamoxifen for hormone-sensitive breast cancer, and raloxifene for osteoporosis.

2
New cards

Clomiphene (Clomid)

A synthetic nonsteroidal estrogen receptor antagonist that stimulates ovulation by blocking the negative feedback of estradiol on LH and FSH secretion, which carries an increased chance of twinning.

3
New cards

Phosphodiesterase Type 5 (PDE5) Inhibitors

Vasodilating agents, including sildenafil (Viagra) and tadalafil (Cialis), that treat erectile dysfunction by preventing the enzymatic degradation of cGMP, thereby maintaining smooth muscle relaxation and penile erection.

4
New cards
<p>Pancreatic Beta-Cell Insulin Secretion Mechanism</p>

Pancreatic Beta-Cell Insulin Secretion Mechanism

A physiological cascade wherein glucose enters via GLUT2, undergoes metabolism to generate ATP, closes ATP-sensitive K+K^+ channels (SUR), depolarizes the plasma membrane, opens voltage-gated Ca2+Ca^{2+} channels, and triggers the exocytosis of insulin and amylin.

5
New cards
<p>Insulin Analogs</p>

Insulin Analogs

Recombinant human insulin molecules engineered with amino acid modifications (at positions 1, 3, 28, 29 on the B chain or 21 on the A chain) to alter kinetics, yielding rapid-acting agents (lispro, aspart, glulisine) or prolonged, basal-release agents (detemir, glargine).

6
New cards

Sulfonylureas

Oral secretagogue antidiabetic drugs (second-generation agents include glipizide, glimepiride, and glyburide) that stimulate insulin release by binding to sulfonylurea receptors (SUR) and closing ATP-dependent K+K^+ channels on pancreatic beta cells.

7
New cards

Metformin (Glucophage)

A biguanide antihyperglycemic drug that suppresses hepatic glucose production and decreases intestinal glucose absorption; it does not cause hypoglycemia but carries a rare, potentially fatal risk of lactic acidosis.

8
New cards

SGLT2 Inhibitors

Antidiabetic drugs, including canagliflozin (Invokana) and dapagliflozin (Farxiga), that inhibit sodium-glucose cotransporter 2 in the kidneys to block glucose reabsorption, with common side effects of urinary tract infections, yeast infections, and dehydration.

9
New cards

DPP-4 Inhibitors

Antihyperglycemic medications such as alogliptin (Nesina) and saxagliptin (Onglyza) that inhibit dipeptidyl peptidase-4, extending the half-life of endogenous GLP-1 incretins to augment glucose-dependent insulin secretion.

10
New cards

Pramlintide (Symlin)

A synthetic amylin analog administered subcutaneously at mealtime alongside insulin in Type 1 and Type 2 diabetes that slows glucose absorption and promotes central satiety.

11
New cards

5-HT35\text{-HT}_3 Receptor

A ligand-gated cation channel subtype of the serotonin receptor family whose activation induces nausea, vomiting, and neuronal excitation.

12
New cards

Serotonin Syndrome

A dangerous toxic state resulting from excessive CNS serotonin levels, presenting clinically with confusion, restlessness, tremors, hyperthermia (fever), coma, and death.

13
New cards

Tricyclic Antidepressants (TCAs)

Antidepressant agents (including secondary amines like desipramine and tertiary amines like amitriptyline) that block the reuptake of norepinephrine and serotonin while producing prominent sedation, anticholinergic effects, antihistaminic actions, and alpha-adrenergic blockade.

14
New cards

Monoamine Oxidase Inhibitors (MAOIs)

Antidepressants such as phenelzine (Nardil), tranylcypromine (Parnate), and isocarboxazid (Marplan) that require strict dietary avoidance of tyramine-containing foods (aged cheeses, wine, beer) and decongestants to avoid life-threatening hypertensive crisis.

15
New cards

Bupropion (Wellbutrin)

A norepinephrine and dopamine reuptake inhibitor (NDRI) that enhances the release and inhibits the reuptake of NE and DA without causing sexual dysfunction; notable adverse effects include agitation, anorexia, and increased libido.

16
New cards

Lithium

A monovalent cation mood stabilizer that shares chemical properties with sodium and dampens neuronal conduction and excitability in bipolar disorder and acute mania; it carries cardiac and renal toxicity and is contraindicated in thyroid conditions.

17
New cards
<p>$$\text{GABA}_A$$ Receptor Complex</p>

GABAA\text{GABA}_A Receptor Complex

A pentameric ligand-gated chloride channel composed of α\alpha, β\beta, and γ\gamma subunits that hyperpolarizes neuronal membranes when bound by GABA; it possesses allosteric modulating sites for benzodiazepines and flumazenil.

18
New cards

Buspirone (BuSpar)

A non-benzodiazepine anxiolytic that acts as a partial agonist at serotonin receptors, providing antianxiety effects without inducing significant sedation, hypnosis, anticonvulsant activity, or skeletal muscle relaxation.

19
New cards

Extrapyramidal Symptoms (EPS)

Motor abnormalities resembling Parkinson's disease—such as dystonic reactions, akathisia, muscle rigidity, and resting tremor—caused by excessive blockade of dopamine D2D_2 receptors in the basal ganglia by antipsychotic medications.

20
New cards

Haloperidol (Haldol)

A high-potency butyrophenone first-generation antipsychotic with potent D2D_2 receptor antagonism that carries a low incidence of sedation and anticholinergic effects but a very high risk of extrapyramidal symptoms (EPS).

21
New cards

Clozapine (Clozaril)

An atypical antipsychotic of moderate potency with very low EPS risk, but associated with serious adverse effects including agranulocytosis (requiring blood monitoring), seizures, weight gain, prominent sedation, and postural hypotension.

22
New cards
<p>SMART (Parkinson's Disease Signs)</p>

SMART (Parkinson's Disease Signs)

A clinical mnemonic capturing the hallmark motor signs of Parkinson's disease: Shuffling gait, Mask-like face, Akinesia, Rigidity, and Tremor.

23
New cards
<p>Basal Ganglia Neurotransmitter Balance</p>

Basal Ganglia Neurotransmitter Balance

A physiological balance model where normal motor behavior requires balanced dopamine (DA) and acetylcholine (ACh) signaling; Parkinson's disease reflects low DA and relatively excessive ACh, whereas Huntington's chorea and Tourette's reflect high DA and low ACh.

24
New cards
<p>Carbidopa (Lodosyn)</p>

Carbidopa (Lodosyn)

A peripheral DOPA decarboxylase inhibitor co-administered with levodopa (as Sinemet) that prevents the peripheral breakdown of L-DOPA into dopamine, drastically increasing L-DOPA brain penetration from 1–3%1\text{--}3\% to 10%10\% while curbing peripheral toxicities like nausea.

25
New cards

Tolcapone (Tasmar)

A catechol-O-methyltransferase (COMT) inhibitor that acts both peripherally and centrally across the blood-brain barrier to reduce the degradation of levodopa and dopamine, though clinically restricted by liver toxicity risk.

26
New cards

Entacapone (Comtan)

A COMT inhibitor that selectively acts in peripheral tissues to prevent the conversion of L-DOPA to 3-O-methyldopa (3-OMD), prolonging L-DOPA's duration of action.

27
New cards

Selegiline (Eldepryl)

An irreversible monoamine oxidase-B (MAO-B) inhibitor that selectively blocks dopamine metabolism within the brain, thereby elevating central dopamine concentrations in Parkinson's disease.

28
New cards
<p>Livedo Reticularis</p>

Livedo Reticularis

A purplish, lace-like mottled vascular skin discoloration primarily affecting the lower extremities, known as a characteristic benign dermatological side effect of amantadine therapy.

29
New cards

Benztropine (Cogentin)

A centrally acting anticholinergic drug used in Parkinson's disease to suppress excessive striatal cholinergic neurotransmission and to treat drug-induced extrapyramidal symptoms in patients taking antipsychotics.